G Petur Nielsen Selected Research

Neoplasm Metastasis (Metastasis)

1/2020	Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis.
9/2019	Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
1/2019	Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.
1/2016	CSPG4 as a prognostic biomarker in chordoma.
7/2014	Programmed cell death ligand 1 expression in osteosarcoma.
11/2010	Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases.
5/2009	Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas.
10/2007	Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Petur Nielsen Research Topics

Disease

65	Neoplasms (Cancer) 03/2024 - 03/2003
17	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 04/2007
14	Chordoma 01/2023 - 09/2009
9	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 07/2009
8	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2007
6	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 01/2005
5	Necrosis 01/2022 - 03/2003
4	Chondrosarcoma 01/2021 - 03/2003
4	Margins of Excision 01/2019 - 07/2010
3	Fibroma (Fibromatosis) 03/2024 - 01/2018
3	Synovial Sarcoma (Synovioma) 03/2024 - 01/2011
3	Bone Cysts (Bone Cyst) 04/2022 - 01/2018
3	Giant Cell Tumors (Giant Cell Tumor) 04/2022 - 01/2016
3	Carcinoma (Carcinomatosis) 05/2021 - 01/2007
3	Giant Cell Tumor of Bone 01/2021 - 01/2016
3	Liposarcoma 01/2020 - 01/2014
3	Lipoma (Lipomata) 01/2020 - 01/2013
2	Neurilemmoma (Schwannoma) 03/2024 - 03/2015
2	Bone Neoplasms (Bone Cancer) 04/2022 - 01/2019
2	Neurofibrosarcoma (MPNST) 10/2019 - 07/2009
2	Tuberous Sclerosis (Bourneville's Disease) 06/2019 - 01/2018
2	Perivascular Epithelioid Cell Neoplasms 06/2019 - 01/2018
2	Fibrosis (Cirrhosis) 01/2019 - 08/2012
2	Pain (Aches) 07/2016 - 11/2015
2	Essential Osteolysis 11/2015 - 12/2006
2	Papillary Carcinoma 08/2015 - 01/2007
1	Fasciitis (Fascitis) 03/2024
1	Angiomyoma (Angioleiomyoma) 03/2024
1	Dermatofibrosarcoma 03/2024
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 03/2024
1	Cicatrix (Scar) 03/2024
1	Neurofibroma 03/2024
1	Glomus Tumor (Glomus Tumors) 03/2024
1	Benign Fibrous Histiocytoma (Dermatofibroma) 03/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2023
1	Wounds and Injuries (Trauma) 04/2022
1	Osteoblastoma 04/2022
1	Aneurysmal Bone Cysts 04/2022
1	Disease Progression 01/2021
1	Histiocytic Sarcoma 01/2021

Drug/Important Bio-Agent (IBA)

10	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2014
9	Keratins (Keratin)IBA 12/2023 - 01/2005
7	DesminIBA 12/2019 - 04/2003
6	Protons (Proton)IBA 01/2023 - 07/2009
6	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2009
5	S100 Proteins (S 100 Protein)IBA 12/2019 - 04/2003
4	Denosumab FDA Link 04/2022 - 01/2016
4	Brachyury protein (Brachyury)IBA 01/2020 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2019 - 02/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 03/2003
3	VimentinIBA 07/2013 - 04/2003
2	CateninsIBA 03/2024 - 12/2023
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
2	ChromatinIBA 01/2023 - 01/2019
2	EWS-FLI fusion proteinIBA 01/2023 - 11/2014
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 10/2017
2	Monoclonal AntibodiesIBA 01/2021 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 05/2009
2	ParaffinIBA 01/2021 - 01/2007
2	Histocompatibility Antigens Class IIBA 01/2021 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 05/2009
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 11/2014
2	MyogeninIBA 10/2019 - 01/2019
2	Histones (Histone)IBA 10/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 09/2019 - 07/2014
2	MicroRNAs (MicroRNA)IBA 09/2019 - 06/2010
2	trans-sodium crocetinate (crocetin)IBA 06/2019 - 01/2018
2	LigandsIBA 01/2016 - 07/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 06/2010
2	Indicators and Reagents (Reagents)IBA 01/2013 - 06/2010
2	CollagenIBA 06/2010 - 07/2003
2	TrabectedinIBA 06/2010 - 03/2003
1	SynaptophysinIBA 12/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2023
1	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	VaccinesIBA 01/2021
1	Xylenes (Xylene)IBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	BuffersIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	AntigensIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 03/2003
16	Radiotherapy 01/2023 - 04/2007
9	Drug Therapy (Chemotherapy) 01/2022 - 03/2003
4	Neoadjuvant Therapy 01/2019 - 11/2011
3	Curettage 01/2022 - 02/2009
2	Adjuvant Radiotherapy 01/2019 - 08/2014
2	Proton Therapy 01/2017 - 06/2010
2	Aftercare (After-Treatment) 09/2009 - 07/2009
1	Negative-Pressure Wound Therapy 04/2022
1	Immunotherapy 01/2021